24 Jan, 2024 10:38 AM
On 31 October 2023, Radiopharm Theranostics Limited (ASX:RAD) (Radiopharm or Company) announced the details of a non-renounceable entitlement offer (Entitlement Offer) to raise approximate...read more
10 Jan, 2024 09:53 AM
Sydney, Australia, 10 January 2024: Chimeric Therapeutics (ASX:CHM, “Chimeric” or the “Company”), an Australian leader in cell, is pleased announce it has received a research...read more
04 Jan, 2024 09:17 AM
SYDNEY, AUSTRALIA – 04 January 2024 – Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical-stage biotechnology company developing nove...read more
27 Dec, 2023 04:49 PM
Austco Healthcare Limited (ASX: AHC) is pleased to announce that Teknocorp, its recently acquired subsidiary, has been awarded an AUD $1.2 million contract to deliver state-of-the-art access control...read more
27 Dec, 2023 09:15 AM
-- Ethics Committee approval received from Hollywood Private Hospital in Perth, WA
-- Patient recruitment to commence shortly
-- Phase 1 study in 21 patients designed to evaluate the safety and ef...read more
22 Dec, 2023 03:16 PM
SYDNEY, AUSTRALIA – 22 December 2023 – Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), advises that its registered office and principal plac...read more
22 Dec, 2023 09:45 AM
-- Successful Site Initiation at Princess Alexandra Hospital, Brisbane for RAD 204 (PDL-1 nanobody) therapeutic Phase 1 trial
-- Phase 1 First-In-Human study in 21 patients designed to evaluate saf...read more
21 Dec, 2023 12:12 PM
SYDNEY, AUSTRALIA – December 21, 2023 – Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical-stage biotechnology company developi...read more
08 Dec, 2023 11:45 AM
On 31 October 2023, Radiopharm Theranostics Limited (ASX:RAD) (Radiopharm or Company) announced the details of a non-renounceable entitlement offer (Entitlement Offer) to raise approximately $10 mil...read more
07 Dec, 2023 11:40 AM
On 25 October 2023, Chimeric Therapeutics Limited (ASX:CHM) (Chimeric or Company) announced the details of a non-renounceable entitlement offer (Entitlement Offer) to raise approximately $10 million...read more